Medifast Announces Third Quarter 2026 Financial Results

What happened

Medifast reported third quarter 2026 revenue of $72.0 million and a net loss of $17.5 million, or $1.57 per diluted share. It had 10,200 active earning coaches and $172.5 million in cash, equivalents, and investment securities with no debt.

Confirmed

Global impact / market context

The company lost money while still holding $172.5 million in cash and no debt, which gives it room to fund operations and its Catalyst cost program. Revenue per coach improved, but revenue depends on recruiting and keeping active coaches who sell products.

Analyst inference

Medifast is spending on its 3.0 strategy, including Trilivy, Reset Fuelings, and a new compensation plan. Those launches raise costs before returns arrive. Investors will compare progress in coach productivity against continued losses and cash use, since cash available funds the turnaround.

Analyst inference

What to watch

1. Watch whether revenue per active earning coach of $7,064 continues rising, since the company says coach productivity improved year-over-year for the fourth consecutive quarter. Confirmed
2. Watch whether completing the launches and executing most of the Catalyst cost program lowers costs enough to narrow the $17.5 million quarterly loss. Proposed
3. Watch the number of active earning coaches, 10,200 in the quarter, because coach count and productivity together drive product revenue and cash available. Analyst inference

Evidence

• Original source link unavailable